Brady records strong revenue boost in ’09; sees substantial areas for growth

Brady plc, provider of trading, risk management and settlement software to the metals and commodities industries, said revenue was up 33% to £8.2m and pretax profit was up 14% to £1.2m in the year to end December 2009.

Chairman Paul Fullagar said the result "demonstrates ongoing success executing the business plan set out in 2008.

"Growth has been achieved across all our revenue streams...

Abcam reports strong growth in 1H ‘09/10; 2H matches expectations so far

Abcam plc, the Cambridge-based bioscience firm that markets antibodies online, reported a 38% increase in sales to £31.8m and 64% rise in pretax profit to £11.2m in the half year to end December 2009.

Sales increased 25% in constant currency terms. 

The company said it was doubling its interim dividend to 5.42p per share; its strategy is now to pay a higher proportion of the full year...

Cambridge Consultants unveils novel prefilled syringe, cutting volume in half

Cambridge Consultants, a tech product design and development firm, announced a novel pre-filled syringe concept ‘Syreen'.

A revolutionary ‘green' syringe design, Syreen is an effective, safe, and easy-to-use drug delivery device for self administration, designed to ease the resource intensity and material wastage associated with traditional syringe development and manufacture.

Instead...

Listed Silicon Fenners show cause for celebration, and concern

It was a mixed month for the top listed tech companies in Silicon Fen. Of the top ten, five saw their shares prices rise, five saw them fall.

And it was a story of the big getting bigger, the smaller struggling. Perhaps that is partly the way of the post GFC world.

The largest three - now icons of the Cambridge Cluster of high tech firms, -sophisticated search software specialists Autonomy, chip...

ANT has good revenue gains in ’09; losses narrow: profitable in 2H

ANT plc, provider of software and services for the delivery of digital TV, said revenue for the year to end December increased 26% to £4.7m., while pre-tax losses narrowed by 38% to £0.6m.

Licence and royalty revenue rose by 28% to £3.7m due to the broadened product range and increase in customer numbers. Professional Services revenue increased 17% to £1.0m (2008: £0.9m).

The...

Previous articles
Domainex collaborates with Breakthrough Breast Cancer, Institute of Cancer Research
Takeda acquires Paradigm Therapeutics
Domino Printing marks 30 years of ops with continued revenue growth; ‘fundamentals’ deliver record 08 results
Alizyme raises £14.5m; appoints new CEO: shares gain 15%
CMR Fuel Cells to hand back £3.8m to shareholders; delist from AIM
Brady’s turnover up 40% in 1H ‘09
Briefs: Pfizer opens stem cell research lab in Cambridge; Cronto does first deal with Commerzbank
CAT on a roll as it turns a profit in Q1 and reports pipeline progress
Market warms to ANT on improved 2H performance despite wider losses in 07
BioWisdom buys LION's bioinformatics business for Eur4m
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Abingworth Management


James Abell
Director and CFO


Abingworth is a long-established venture capital firm specialising in investment in life science biomedical companies. With offices in London, Cambridge, Menlo Park and Boston, Abingworth is active on both sides of the Atlantic and has backed more than 90 developing life science/medical businesses.

[Abingworth Management's profile]


Top20 Index




Currently: 129.81

Best Mortgage
When you need the best mortgage, click here and be assured of a quick response.

Marcus Evans
Marcus Evans can offer the business solutions and opportunities you need.

Marcus Evans Scam
Combat corruption in your company by attending a Marcus Evans scam conference.

IFL
IFL are leaders in the Chrome industry. To find out more visit www.ifml.com

Free Business Directory
Find loads of info and advertise your business on the free business directory!